FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067991 [Registered on: 28/05/2024] Trial Registered Prospectively
Last Modified On: 17/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of post-operative pain reducing effect of local anaesthetic drug (lidocaine) administration during surgery using two routes of administration(intraperitoneal instillation versus subserosal infiltration)in laparoscopic cholecystectomy. 
Scientific Title of Study   Effect of intraperitoneal instillation versus subserosal infiltration of lidocaine on post-operative pain in laparoscopic cholecystectomy in a tertiary care hospital- A randomized controlled clinical trial 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rajat 
Designation  DNB PG Resident 
Affiliation  Sikkim Manipal Institute of Medical Sciences. 
Address  General surgery department , level 4 central referral hospital,Sikkim Manipal Institute Of Medical Sciences,5th mile, upper Tadong, Gangtok.

East
SIKKIM
737102
India 
Phone  8813914530  
Fax    
Email  rajatsaini454@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kumar Nishant 
Designation  Professor and head of department  
Affiliation  Sikkim Manipal Institute of Medical Sciences. 
Address  General surgery department , level 4, Central referral hospital , Sikkim Manipal Institute Of Medical Sciences,5th mile, upper Tadong, Gangtok.

East
SIKKIM
737102
India 
Phone  8670679466  
Fax    
Email  dr.k.nishant@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rajat 
Designation  DNB PG Resident 
Affiliation  Sikkim Manipal Institute of Medical Sciences. 
Address  General surgery department, level 4, Central referral hospital, Sikkim Manipal Institute Of Medical Sciences,5th mile, upper Tadong, Gangtok.

East
SIKKIM
737102
India 
Phone  8813914530  
Fax    
Email  rajatsaini454@gmail.com  
 
Source of Monetary or Material Support  
Sikkim Manipal Institute of Medical Sciences,5th mile, Upper tadong, Gangtok, Sikkim, 737102  
 
Primary Sponsor  
Name  Dr Rajat 
Address  Sikkim Manipal Institute of Medical Sciences, 5th Mile, Upper Tadong, Gangtok, Sikkim. 737102. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajat  Central Referral Hospital, Sikkim Manipal Institute of Medical Sciences   General Surgery Department, level 4, Central referral hospital, 5th Mile, Upper Tadong, Gangtok.
East
SIKKIM 
8813914530

rajatsaini454@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMIMS Institution Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Intraperitoneal instillation of lidocaine.  A 10ml of 1% lidocaine (preservative free) shall be instilled slowly over the visceral peritoneum of calots triangle under direct visualization. There will be a elective wait for 5-6 minutes after the drug delivery to allow the drug to be spread and fixed. 
Intervention  Subserosal infiltration of lidocaine   A fine laparoscopic needle(20G) will be used for infiltration of 5ml 1% lidocaine (preservative free) in anterior serosa of Calots triangle after visually ascertaining that there is no puncture of vascular and ductal structures. The procedure will be repeated with 5ml of 1% lidocaine (preservative free) for posterior serosa of Calots triangle.There will be a elective wait for 5-6 minutes after drug delivery to allow the drug to spread and fix. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  Patients undergoing elective laparoscopic cholecystectomy.  
 
ExclusionCriteria 
Details  1. Jaundice
2. Pregnancy
3. Complicated morbid anatomy or very difficult dissection(Nassar scale III,IV,V)
4. Gall bladder malignancy
5. Any deviation from the proposed process of laparoscopy cholecystectomy, including conversion to open cholecystectomy
6. Equipment failure affecting duration of surgery 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Post-operative pain using visual analog scale (VAS).  At 1 hour, 4 hours, 12 hours and 24 hours post-operatively.  
 
Secondary Outcome  
Outcome  TimePoints 
1. Shoulder tip pain.
2. Post-operative nausea and vomiting (PONV). 
At 1 hour, 4 hour, 12 hours and 24 hours post operatively 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Introduction
The most commonly performed laparoscopic surgery is laparoscopic cholecystectomy. But, like all surgical interventions this ’very common’ procedure is associated with its own complications, the commonest one being postoperative pain. The main reason for staying overnight in the hospital on the day of surgery is pain. Different analgesic interventions have been investigated for their effect on early pain after laparoscopic cholecystectomy including patient controlled IV anesthesia, oral opioids, and opioid like pain killers, NSAIDs and intravenous corticosteroids. Although effective, they have systemic side effects. An ideal pain relief method has maximal local action and minimal systemic side effect. Local anesthetic drugs (LADs) are being used increasingly in the intra-operative period for pain management. Their application is not only limited to the skin incisions but can also be instilled into the peritoneal cavity and subserosa of Calot’s triangle to provide pain relief. Our study is an attempt to compare efficacy the intraperitoneal instillation of versus sub-serosal infiltration of Lignocaine in providing post-operative pain relief.

Research question
Which method of pre-emptive analgesia shows superior effectiveness in alleviating postoperative pain in patients undergoing laparoscopic cholecystectomy between subserosal infiltration and intraperitoneal instillation of 10 ml 1% lidocaine?

Research hypothesis
Null Hypothesis (H0): There is no difference in post operative pain in patients undergoing laparoscopic cholecystectomy by sub-serosal infiltration of 10 ml 1% lidocaine in comparison with  intra-peritoneal instillation of 10 ml 1% lidocaine.
Alternate Hypothesis (H1): Sub-serosal infiltration of 10 ml 1% lidocaine is different to intraperitoneal instillation of 10 ml 1% lidocaine in alleviating postoperative pain in patients undergoing laparoscopic cholecystectomy.

Aims and objectives
Primary objective:
To compare the difference in post-operative pain in patients undergoing laparoscopic cholecystectomy between pre-dissection sub-serosal infiltration of 10 ml 1% lidocaine and intra-peritoneal instillation of 10 ml 1% lidocaine.

Secondary objective:
1. To compare shoulder tip pain between the two groups
2. To compare post-operative nausea and vomiting between the two groups
3. Subgroup analysis of difference in outcome parameters between the two groups on the basis of:
a. Demographic and anthropometric factors
b. Comorbidities
c. Sonographic findings
Methodology
Selection criteria
All the patients who will undergo laparoscopic cholecystectomy between April and September will be invited to participate in the study. All the patients who consent to be part of the study will be included and randomized as stated above.

Inclusion Criteria:
1. Patients undergoing elective laparoscopic cholecystectomy between the age 18 years to 55 years.
Exclusion Criteria:
1. Jaundice 
2. Pregnancy
3. Complicated morbid anatomy or very difficult dissection(Nassar scale III,IV,V)
4. Gall bladder malignancy
5. Any deviation from the proposed process of laparoscopy cholecystectomy, including conversion to open cholecystectomy
6. Equipment failure affecting duration of surgery

Standardization of procedure:
Patient included in the study after obtaining informed written consent shall be evaluated for as protocol including requisite pre-operative clinical evaluation and investigations. They shall be subjected to standard 3 o 4 port laparoscopic cholecystectomy. Supra umbilical 10mm port will be placed by Hasson’s open method and other ports were placed under peritoneoscopic visualization after CO2 insufflation to 12mmhg. After carrying out  general abdominal inspection gall bladder will be visualized. Traction will be applied over the gall bladder to identify the calot’s triangle. In group A, 10ml of 1% lidocaine (preservative free) shall be instilled slowly over the visceral peritoneum of Calot’s triangle slowly under direct visualization. In group B, a fine laparoscopic needle (20G) will be used to inject the 5ml of 1% lidocaine (preservative free) within the anterior serosa of Calot’s triangle after visually ascertaining that there is no puncture of vascular and ductal structures. The procedure will be repeated with 5ml of 1% lidocaine for posterior serosa of Calot’s triangle as well. In both groups there will be a elective wait of 5-6 minutes after drug delivery to allow the drug to be spread and fixed. Cholecystectomy shall be performed in standard technique and gall bladder shall be extracted through the umbilical port-site. 2% lidocaine port-site field block will be provided to all patients prior to dressing application. Standard intra-op and post-op analgesia will be provided to all patients. Post-op rescue analgesics will be given (diclofenac sodium 75mg) and its timing will be noted. Surgery shall performed by surgical consultants. A blinded observer shall be noting the post-operative VAS and vitals in the study proforma.

Data analysis:
Data will be analyzed using Microsoft excel and SPSS version 27. Graphical presentation of data shall be done whenever applicable. Appropriate techniques will be used for analysis. Numerical parameters will be compared by using student’s t test and/or ANOVA. Nominal data shall be compared using non-parameter test like chi-squared and Mann Whitney U test. Test continuous variables will be presented as mean and standard deviation, and categorical variables will be presented as frequency and precent. Cut-off p-value for significance shall be =<0.05 for all statistical tests.

 
Close